Home

szolgáltatás lejtő Lírai overall survival pdac stage 1 hüvelykujj Hűségesen számláló

Cancers | Free Full-Text | Prognosticators for Patients with Pancreatic  Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or  Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy
Cancers | Free Full-Text | Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy

Cumulative survival rates of patients with stage IIB pancreatic... |  Download Scientific Diagram
Cumulative survival rates of patients with stage IIB pancreatic... | Download Scientific Diagram

Outcomes of patients with initially locally advanced pancreatic  adenocarcinoma who did not benefit from resection: a prospective cohort  study | BMC Cancer | Full Text
Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study | BMC Cancer | Full Text

Frontiers | Circulating Cell-Free Tumor DNA in Advanced Pancreatic  Adenocarcinoma Identifies Patients With Worse Overall Survival
Frontiers | Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival

Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer:  a contemporary analysis | Scientific Reports
Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis | Scientific Reports

Overall survival in patients with pancreatic cancer receiving matched  therapies following molecular profiling: a retrospective analysis of the  Know Your Tumor registry trial - The Lancet Oncology
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology

Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable  Pancreatic Ductal Adenocarcinoma
Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma

Stratified survival of resected and overall pancreatic cancer patients in  Europe and the USA in the early twenty-first century: a large,  international population-based study | BMC Medicine | Full Text
Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text

Association between type 2 diabetes and 5-year overall survival in early-stage  pancreatic cancer: a retrospective cohort study [PeerJ]
Association between type 2 diabetes and 5-year overall survival in early-stage pancreatic cancer: a retrospective cohort study [PeerJ]

A Review of Recent Real-World Evidence Data in Metastatic Pancreatic Cancer
A Review of Recent Real-World Evidence Data in Metastatic Pancreatic Cancer

Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to  Improved Outcomes: A Propensity Score-Matched Analysis
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis

Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to  Improved Outcomes: A Propensity Score-Matched Analysis
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis

Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to  Improved Outcomes: A Propensity Score-Matched Analysis - ScienceDirect
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis - ScienceDirect

Pancreatic Cancer Survival Rate – Pancreatic Cancer Action Network
Pancreatic Cancer Survival Rate – Pancreatic Cancer Action Network

Overall survival in patients with pancreatic cancer according to the... |  Download Scientific Diagram
Overall survival in patients with pancreatic cancer according to the... | Download Scientific Diagram

The actual 5-year survivors of pancreatic ductal adenocarcinoma based on  real-world data | Scientific Reports
The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data | Scientific Reports

JCM | Free Full-Text | C-Reactive Protein and Neutrophil/Lymphocytes Ratio:  Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic  Cancer Patients
JCM | Free Full-Text | C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients

Survival and Prognostic Factors in Pancreatic and Ampullary Cancer |  Anticancer Research
Survival and Prognostic Factors in Pancreatic and Ampullary Cancer | Anticancer Research

Cancers | Free Full-Text | Comparing Survival after Resection of Pancreatic  Cancer with and without Pancreatic Cysts: Nationwide Registry-Based Study
Cancers | Free Full-Text | Comparing Survival after Resection of Pancreatic Cancer with and without Pancreatic Cysts: Nationwide Registry-Based Study

Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic  ductal adenocarcinoma: 667 patients' experience within a population-based  study - Tai-Jan Chiu, Yung-Yeh Su, Shih-Hung Yang, Chung-Pin Li, Li-Yuan  Bai, Nai-Jung Chiang, Shih-Chang
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study - Tai-Jan Chiu, Yung-Yeh Su, Shih-Hung Yang, Chung-Pin Li, Li-Yuan Bai, Nai-Jung Chiang, Shih-Chang

Impact of Borderline Resectability in Pancreatic Head Cancer on Patient  Survival: Biology Matters According to the New International Consensus  Criteria | Annals of Surgical Oncology
Impact of Borderline Resectability in Pancreatic Head Cancer on Patient Survival: Biology Matters According to the New International Consensus Criteria | Annals of Surgical Oncology

Frontiers | Prognostic Factors and Effect of Adjuvant Chemoradiation  Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph  Node Metastasis or R1 Resection
Frontiers | Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection